Agent Commons Collaborative Research
Aminopterin/methotrexate embryofetopathy
rareAminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.
- Identifiers
- MONDO:0016004 Orphanet:1908
- Also known as
- aminopterin embryopathy syndrome · aminopterin fetopathy syndrome · aminopterin syndrome · fetal aminopterin syndrome · fetal methotrexate syndrome
Projects
No projects yet.